search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection prevention


property is related mainly to the biofilm structure itself. Bacteria in biofilm form can develop a “protective” layer, which is hard to penetrate with commonly-used chemical agents, including disinfectants and antibiotics. An endoscope-associated outbreak of


OXA 181 carbapenemase-producing Klebsiella Pneumonia showed that a significantly higher concentration of disinfectant (compared to standard concentration) was needed to achieve efficacy against this pathogen in biofilm form.5


Why environmental disinfection matters Environmental surfaces serve as a major reservoir for MDROs. Pathogens spread by colonised or infected patients accumulate on high-touch surfaces (i.e. bed rails, monitors, doorknobs and infusion pumps), where they can persist for days or even months. When healthcare workers touch these surfaces and subsequently touch patients, they unwittingly facilitate transmission, posing a risk of infection. Multiple reviews and guidelines emphasise


the role of environmental disinfection as a key pillar in preventing MDRO spread: l The CDC identifies enhanced environmental disinfection as one of the core interventions (alongside hand hygiene, equipment disinfection, and contact precautions), which has successfully reduced MDRO rates across healthcare facilities, internationally.1


l A 2025 systematic review and network meta- analysis of 97 studies found that bundles incorporating environmental cleaning (ENV) were among the most effective interventions for reducing MDRO acquisition, infection, and colonisation. For example, standard precautions + contact precautions + environmental cleaning (SP + CP + ENV) achieved an exceptionally low transmission rate ratio (RR) of 0.04–0.09, demonstrating its high efficacy across settings.6


l The British Medical Journal (BMJ) Making Healthcare Safer IV review also found evidence – though of varying certainty – that environmental decontamination can reduce infection risk and is beneficial when combined with other measures such as decolonisation and cohorting.7


a 2025 commentary in the American Journal of Infection Control, disinfectants registered by the EPA continue to be effective against MDROs, and there is no evidence that antibiotic resistance mechanisms confer protection against typical healthcare disinfectants.2


This distinction is


crucial: while antibiotics must navigate complex intracellular mechanisms, disinfectants in the majority of cases act broadly, hitting multiple targets like proteins, cell membranes, and nucleic acids and mitochondria. Such a mode of action makes disinfection a reliable defence, even as antimicrobial resistance worsens.


Disinfection is


not merely an adjunct; it is one of the most consistently effective measures in MDRO infection prevention and resistance spread.


Disinfection works even in the case of drug resistance A common misconception is that MDRO resistance to antibiotics implies resistance to disinfectants. However, drug resistance does not equate to disinfectant resistance. According to


26 www.clinicalservicesjournal.com I April 2026


Routine environmental disinfection Standard routine surface and equipment disinfection using disinfectants, with confirmed efficacy according latest EN standards for healthcare applications – described in EN 14885, remains the backbone of environmental control programmes. Daily disinfection of high-touch surfaces, patient rooms, bathrooms, and shared medical equipment dramatically reduces bioburden. Terminal disinfection of rooms previously occupied by MDRO-positive patients is essential. Terminal disinfection – combined with contact precautions, equipment decontamination and hand hygiene – make MDRO transmission significantly less likely, as validated in multiple systematic reviews and outbreak studies.6 Devices such as blood pressure cuffs,


stethoscopes, glucometers, and mobility aids often carry MDROs between patients. Invasive devices, such as flexible endoscopes, can cause the same risk. Studies consistently show that improved disinfection protocols for medical


devices contribute significantly to reducing cross-transmission risk.8


High-risk settings where disinfection is especially critical Transplantation units, burn treatment wards, isolation rooms and operating rooms also require the highest level of diligence in the implementation of hygiene protocols, as each infection can be extremely dangerous for sensitive patients. ICUs host patients with invasive devices (ventilators, catheters, central lines) and compromised immunity. MDRO infections in ICUs carry mortality rates exceeding 50%, especially in Carbapenem- resistant Klebsiella pneumoniae (CRKP) bloodstream infections. Effective environmental disinfection in ICUs is therefore a life-saving intervention.9


Variability in disinfection quality Suboptimal practices – such as inadequate contact time, missed surfaces, or incorrect dilution – significantly reduce efficacy. Many hospitals lack standardised auditing or adequate training.


Pathogen adaptation to active substances – Karpinski Index The potential for adaptation to chemical compounds has so far been proven for: chlorhexidine gluconate,10 chloride,11


cetylpiridinum triclosan,12 hydrogen peroxide and


povidone-iodine.13 Those findings have been confirmed by


numerous studies, showing that Candida albicans can develop adaptation to typically used concentration of sodium hypochlorite


jarun011 - stock.adobe.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84